European Pharmaceutical Review

DECEMBER 20, 2023

In October 2023, the European Parliament (EP) proposed revisions to the European Commission proposals with diverging views on various topics set out through two documents. In October 2023, the European Parliament (EP) proposed revisions to the European Commission proposals with diverging views on various topics set out through two documents.

Biosimilars 98

Biosimilars Labelling Documentation 98

GMPSOP

FEBRUARY 25, 2023

Finished product samples are drowned from packed products to check if the labels are applied correctly, batch number and expiry dates are correct and legible. You will also check printed labels that are affixed on primary containers display correct information (e.g., Additional documents included each month.

Labelling 52

Labelling Packaging Documentation Pharmaceutical Manufacturing 52

Pharma in Brief

JANUARY 17, 2021

The Court found that the prior art documents cited by Pharmascience ( Pinchasi 2007 and Karussis 2006 ) neither disclosed nor enabled the asserted claims of the 437 Patent. The Court found that the statements in Karussis 2006 were “based on hypothesis and speculation, and not evidence-based.”. The Court held: No disclosure.

Dosage 52

Dosage Documentation Labelling 52

The Thyroid Pharmacist

JANUARY 20, 2023

Please consider the following and be sure to read the precautions on individual labels before you try a new herb, supplement, or blend. (In Holy Basil ( Ocimum sanctum ) The anti-inflammatory effects of holy basil (also known as tulsi) have been documented in many in vitro and in vivo studies. 2006 Feb 16;78(12):1287-92.

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Diabetes Immunity Immunization 98